Table 1.
Characteristics of the study groups at the time of collecting adipose tissues.
| Control | MS | EMPA | GLI | |
|---|---|---|---|---|
| Weight (g) | 27.17 ± 1.02 | 42.61 ± 2.27 * | 38.12 ± 4.50 * | 38.88 ± 5.21 * |
| Fasting glucose (mg/dL) | 144.60 ± 21.98 | 155.00 ± 11.86 | 130.50 ± 20.51 | 180.40 ± 17.70 *,#,† |
| Cholesterol (mg/dL) | 85.28 ± 6.08 | 133.69 ± 9.04 * | 98.92 ± 13.87 # | 110.93 ± 4.89 *,# |
| LDL (mg/dL) | 9.50 ± 2.03 | 16.72 ± 2.86 * | 11.36 ± 1.56 | 15.54 ± 1.37 *,† |
| HDL (mg/dL) | 75.35 ± 7.13 | 106.21 ± 9.95 * | 94.05 ± 0.73 | 112.80 ± 5.61 *,† |
| Triglyceride (mg/dL) | 64.77 ± 5.35 | 82.44 ± 15.95 | 44.41 ± 18.64 | 36.19 ± 8.91 *,# |
EMPA: Metabolic syndrome with empagliflozin; GLI: Metabolic syndrome with glibenclamide; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; MS: Metabolic syndrome; *: p-value < 0.05 compared with the control group; #: p-value < 0.05 compared with the MS group; †: p-value < 0.05 compared with the EMPA group.